Dr. David Furman is the Director of the 1000 Immunomes Project at the Stanford School of Medicine and Associate Professor and Head of the AI Core at the Buck Institute. Dr. Furman’s research portfolio involves multiple layers of human biology including systems medicine, translational immunology, preventative healthcare, aging and precision longevity. With over 15 years of experience in the field of inflammation as it relates to accelerated aging mechanisms, Dr. Furman’s has developed technologies to track the health status of a person and recently, in 2022, he initiated collaborations with the Human Research Program at NASA and Space X to develop accelerated models for aging. As part of Dr. Furman’s entrepreneurial work, he founded the Inflammaging Institute; the Stanford spin-off Edifice Health Inc.; and the Buck Institute spin-off, Cosmica Biosciences Inc. with applications in aging-reversing drugs and natural compounds for precision longevity.

Dr. Furman has published over 45 scientific articles in top-tier journals such as Cell, Nature Medicine, PNAS, The Lancet, and others, and is the inventor of over 25 patents.